Fisher Asset Management LLC Increases Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 317,393 shares of the company’s stock after acquiring an additional 152 shares during the quarter. Fisher Asset Management LLC’s holdings in Prestige Consumer Healthcare were worth $22,884,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Evergreen Capital Management LLC raised its holdings in shares of Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock valued at $216,000 after buying an additional 160 shares during the period. Miller Howard Investments Inc. NY grew its position in Prestige Consumer Healthcare by 2.2% in the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock valued at $534,000 after acquiring an additional 165 shares in the last quarter. OLD National Bancorp IN raised its stake in shares of Prestige Consumer Healthcare by 4.4% during the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock valued at $287,000 after purchasing an additional 168 shares during the period. Huntington National Bank lifted its position in shares of Prestige Consumer Healthcare by 39.9% during the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after purchasing an additional 181 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the topic of a number of recent analyst reports. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reaffirmed a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus price target of $83.67.

Prestige Consumer Healthcare Trading Up 1.2 %

NYSE PBH opened at $84.17 on Thursday. The company’s fifty day moving average price is $74.97 and its two-hundred day moving average price is $70.97. The company has a market capitalization of $4.16 billion, a price-to-earnings ratio of 20.48, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $86.36. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The business had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. During the same period last year, the firm earned $1.07 earnings per share. The company’s revenue for the quarter was down .9% compared to the same quarter last year. As a group, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total transaction of $743,166.00. Following the completion of the sale, the executive vice president now owns 18,365 shares of the company’s stock, valued at $1,505,930. This represents a 33.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Ronald M. Lombardi sold 10,875 shares of the stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 38,810 shares of company stock worth $3,187,300. 1.60% of the stock is currently owned by insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.